Search Results - "Lauritsen, Clinton"
-
1
CGRP Monoclonal Antibodies for Migraine: Rationale and Progress
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01-12-2017)“…Calcitonin gene-related peptide (CGRP), a neuropeptide abundant in the trigeminal system and widely expressed in both the peripheral and central nervous…”
Get full text
Journal Article -
2
Real-world study of intranasal ketamine for use in patients with refractory chronic migraine: a retrospective analysis
Published in Regional anesthesia and pain medicine (01-12-2023)“…IntroductionSubanesthetic ketamine infusion has been used for managing refractory headache in inpatient or outpatient infusion settings. Intranasal ketamine…”
Get full text
Journal Article -
3
Lidocaine infusions for refractory chronic migraine: a retrospective analysis
Published in Regional anesthesia and pain medicine (01-07-2022)“…IntroductionPatients with refractory chronic migraine have poor quality of life. Intravenous infusions are indicated to rapidly ‘break the cycle’ of pain…”
Get full text
Journal Article -
4
Current Treatment Options: Vestibular Migraine
Published in Current treatment options in neurology (01-11-2017)“…Opinion statement Vestibular migraine (VM) is a disorder with a spectrum of clinical presentations and among the most common causes of chronic vestibular…”
Get full text
Journal Article -
5
Beyond the Raskin Protocol: Ketamine, Lidocaine, and Other Therapies for Refractory Chronic Migraine
Published in Current pain and headache reports (01-12-2021)“…Purpose of Review The purpose of this review is to discuss the available evidence and therapeutic considerations for intravenous drug therapy for refractory…”
Get full text
Journal Article -
6
Central Nervous System Involvement of Multiple Myeloma Presenting as Short-lasting Unilateral Neuralgiform Headache with Conjunctival Injection and Tearing: A Case Report
Published in Neurohospitalist (01-07-2022)“…Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) and short-lasting unilateral neuralgiform headache attacks with…”
Get full text
Journal Article -
7
Current Treatment Options: Headache Related to Menopause—Diagnosis and Management
Published in Current treatment options in neurology (01-04-2018)“…Purpose of review Menopause is a life-changing event in numerous ways. Many women with migraine hold hope that the transition to the climacteric state will…”
Get full text
Journal Article -
8
Ketamine for Refractory Headache: A Retrospective Analysis
Published in Regional anesthesia and pain medicine (01-11-2018)“…BACKGROUND AND OBJECTIVESThe burden of chronic headache disorders in the United States is substantial. Some patients are treatment refractory. Ketamine, an…”
Get full text
Journal Article -
9
DHE-Induced Peripheral Arterial Vasospasm in Primary Raynaud Phenomenon: Case Report
Published in Neurohospitalist (01-04-2019)“…Dihydroergotamine (DHE) is primarily a serotonin 5HT1B and 5HT1D receptor agonist used for acute migraine treatment. It is associated with acute…”
Get full text
Journal Article -
10
Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series
Published in Journal of headache and pain (22-11-2016)Get full text
Journal Article -
11
Mexiletine for the Treatment of Refractory Chronic Migraine: A Retrospective Chart Review (P6-12.005)
Published in Neurology (09-04-2024)“…Abstract only…”
Get full text
Journal Article -
12
Safety and Efficacy of Repetitive Dihydroergotamine Infusion for the Acute Treatment of Refractory Chronic Migraine in Hospitalized Patients with Vascular Risk Factors (4366)
Published in Neurology (13-04-2021)“…Abstract only…”
Get full text
Journal Article -
13
Safety, tolerability, and effectiveness of repetitive intravenous dihydroergotamine for refractory chronic migraine with cardiovascular risk factors: A retrospective study
Published in Headache (01-10-2023)“…BackgroundDihydroergotamine (DHE), like triptans, is contraindicated in patients with ischemic heart disease or coronary vasospasm. Its true safety,…”
Get full text
Journal Article -
14
Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series
Published in Journal of headache and pain (01-12-2016)“…Background Refractory migraine is a challenging condition with great impact on health related quality of life. Intravenous (IV) ketamine has been previously…”
Get full text
Journal Article -
15
Ketamine for Refractory Chronic Migraine: An Observational Pilot Study and Metabolite Analysis
Published in Journal of clinical pharmacology (01-11-2021)“…Patients with refractory chronic migraine have substantial disability and have failed many acute and preventive medications. When aggressive intravenous…”
Get full text
Journal Article -
16
Quality Improvement Project: Improving the Follow Up of Patients at the Neurology Resident’s Clinic after Hospital Discharge (S25.006)
Published in Neurology (06-04-2015)“…Abstract only…”
Get full text
Journal Article -
17
-
18
DHE-Induced Peripheral Arterial Vasospasm in Primary Raynaud Phenomenon: Case Report
Published in The Neurohospitalist (01-04-2019)Get full text
Report